A randomized, double-blinded, placebo-controlled study in healthy, non-immune adults to determine the schizonticidal activity of tafenoquine after challenge with Plasmodium falciparum blood stage parasites.
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Tafenoquine (Primary) ; Artemether/lumefantrine; Primaquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors 60 Degrees Pharmaceuticals Australia
- 01 Nov 2018 Results published in the Clinical Infectious Diseases
- 11 Jul 2017 Status changed from recruiting to completed.
- 02 Feb 2017 Status changed from not yet recruiting to recruiting.